Literature DB >> 18285486

Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.

A Gomez-Lopez1, A Alastruey-Izquierdo, D Rodriguez, B Almirante, A Pahissa, J L Rodriguez-Tudela, M Cuenca-Estrella.   

Abstract

We describe the prevalences and susceptibility profiles of two recently described species, Candida metapsilosis and Candida orthopsilosis, related to Candida parapsilosis in candidemia. The prevalences of these species (1.7% for C. metapsilosis and 1.4% for C. orthopsilosis) are significant. Differences observed in their susceptibility profiles could have therapeutic importance.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18285486      PMCID： PMC2292570          DOI： 10.1128/AAC.01595-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.

Authors:  Manuel Cuenca-Estrella; Dolores Rodriguez; Benito Almirante; Juliette Morgan; Ana Maria Planes; Manel Almela; José Mensa; Ferran Sanchez; Josefina Ayats; Montserrat Gimenez; Margarita Salvado; David W Warnock; Albert Pahissa; Juan L Rodriguez-Tudela
Journal:  J Antimicrob Chemother       Date:  2004-12-23       Impact factor: 5.790

2.  Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

Authors:  Benito Almirante; Dolors Rodríguez; Benjamin J Park; Manuel Cuenca-Estrella; Ana M Planes; Manuel Almela; Jose Mensa; Ferran Sanchez; Josefina Ayats; Montserrat Gimenez; Pere Saballs; Scott K Fridkin; Juliette Morgan; Juan L Rodriguez-Tudela; David W Warnock; Albert Pahissa
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Confirmation of the distinct genotype groups within the form species Candida parapsilosis.

Authors:  B Roy; S A Meyer
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

4.  In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.

Authors:  M A Pfaller; L Boyken; R J Hollis; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

5.  Genetic diversity of the internal transcribed spacers (ITS) and 5.8S rRNA genes among the clinical isolates of Candida parapsilosis in Brazil and Japan.

Authors:  Soji Iida; Tamae Imai; Toyoko Oguri; Katsuko Okuzumi; Ademar Yamanaka; Maria Luiza Moretti-Branchini; Kazuko Nishimura; Yuzuru Mikami
Journal:  Nihon Ishinkin Gakkai Zasshi       Date:  2005

6.  Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.

Authors:  Arianna Tavanti; Amanda D Davidson; Neil A R Gow; Martin C J Maiden; Frank C Odds
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003.

Authors:  Benito Almirante; Dolors Rodríguez; Manuel Cuenca-Estrella; Manel Almela; Ferran Sanchez; Josefina Ayats; Carles Alonso-Tarres; Juan L Rodriguez-Tudela; Albert Pahissa
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

8.  Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR.

Authors:  Guizhen Luo; Thomas G Mitchell
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models.

Authors:  Attila Gácser; Wilhelm Schäfer; Jerome S Nosanchuk; Siegfried Salomon; Joshua D Nosanchuk
Journal:  Fungal Genet Biol       Date:  2007-02-21       Impact factor: 3.495

10.  Three distinct genotypes within Candida parapsilosis from clinical sources.

Authors:  D Lin; L C Wu; M G Rinaldi; P F Lehmann
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948
View more
  40 in total

1.  Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Authors:  Emilia Cantón; Javier Pemán; Guillermo Quindós; Elena Eraso; Ilargi Miranda-Zapico; María Álvarez; Paloma Merino; Isolina Campos-Herrero; Francesc Marco; Elia Gomez G de la Pedrosa; Genoveva Yagüe; Remedios Guna; Carmen Rubio; Consuelo Miranda; Carmen Pazos; David Velasco
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Comparison of commercial methods and the CLSI broth microdilution to determine the antifungal susceptibility of Candida parapsilosis complex bloodstream isolates from three health institutions in Rio de Janeiro, Brazil.

Authors:  Maria Helena G Figueiredo-Carvalho; Leonardo S Barbedo; Manoel M E Oliveira; Fábio Brito-Santos; Rodrigo Almeida-Paes; Rosely M Zancopé-Oliveira
Journal:  Mycopathologia       Date:  2014-06-22       Impact factor: 2.574

3.  Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species.

Authors:  Guillermo Garcia-Effron; Emilia Canton; Javier Pemán; Amanda Dilger; Eva Romá; David S Perlin
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

4.  Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience).

Authors:  Bilgul Mete; Esra Yerlikaya Zerdali; Gokhan Aygun; Nese Saltoglu; Ilker Inanc Balkan; Ridvan Karaali; Sibel Yildiz Kaya; Berna Karaismailoglu; Abdurrahman Kaya; Seval Urkmez; Gunay Can; Fehmi Tabak; Recep Ozturk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-09-15       Impact factor: 3.267

5.  Identification of Candida parapsilosis Sensu Lato in Pediatric Patients and Antifungal Susceptibility Testing.

Authors:  Maria Emilia Cattana; Catiana Dudiuk; Mariana Fernández; Florencia Rojas; Liliana Alegre; Susana Córdoba; Guillermo Garcia-Effron; Gustavo Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 6.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

7.  Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.

Authors:  Shawn R Lockhart; Shawn A Messer; Michael A Pfaller; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

Review 8.  Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Linda Holland; Geraldine Butler; Attila Gacser; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

9.  Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China.

Authors:  Xiaobo Feng; Bo Ling; Xianwei Yang; Wanqing Liao; Weihua Pan; Zhirong Yao
Journal:  Mycopathologia       Date:  2015-07-31       Impact factor: 2.574

10.  Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis.

Authors:  Andrew M Borman; Christopher J Linton; Debra Oliver; Michael D Palmer; Adrien Szekely; Frank C Odds; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.